Metacen Therapeutics (CEO Myoung-Gyu Park) and the AGEs Society have renewed and launched rTG Omega-3 EO Premium.
The renewed product is designed to enhance both safety and absorption compared to conventional omega-3 products. It is specifically engineered to prevent oxidation of raw materials, oxidation during distribution, and even oxidation that may occur within the body after consumption.
The product contains EPA and DHA-containing oil (refined fish oil), d-tocopherol, and clove leaf oil. Additional ingredients include soybean oil, beeswax, L-tryptophan, L-histidine, and soybean lecithin.
Each package consists of two containers with a total of 60 capsules (103.2g). The recommended dosage is one capsule, twice a day.
A company representative stated, "rTG Omega-3 EO Premium is a breakthrough product that addresses both lipid toxins and glycotoxin issues, overcoming the limitations of traditional omega-3 products. We expect it to become a safe and effective health management solution for consumers."

Reporter: Hyekyeong Kang (khk@dailypharm.com)
Source: [DailyPharm](https://www.dailypharm.com)